Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


President Signs FDA User Fee Legislation


 
Sen. Lamar Alexander

On Aug. 18, President Donald Trump signed bipartisan legislation authored by Senate health committee Chairman Lamar Alexander (R-Tenn.) and Ranking Member Patty Murray (D-Wash.) intended to speed safe drugs and medical devices into patients' medicine cabinets and doctors' offices, while maintaining safety and effectiveness standards.

"The legislation signed by the president today will speed the FDA's work to review new cures and treatments and get them into patients' medicine cabinets and doctors' offices," Alexander said after the legislation was signed. "The first step was last year's passage of 21st Century Cures to spur medical research, and this is the next step -- legislation to help ensure that these breakthroughs in research make it to patients."

"I'm pleased that Democrats and Republicans in Congress were able to set aside partisanship, work together to put patients and families first, and ensure the FDA continues to have the resources it needs to advance safe, effective medical products for people across the country," Murray said. "This legislation reflects years of hard work by the Obama Administration, as well as members on both sides of the aisle, and I want to express my appreciation in particular to Chairman Alexander for his leadership. I hope we can build on this step forward with additional efforts to strengthen healthcare for the communities we all serve."

The legislation was passed by the Senate on Aug. 3 by a vote of 94-1.

The legislation includes four different user fee agreements that must be reauthorized by Sept. 30. The bill is virtually identical to legislation overwhelmingly approved by the Senate's health committee on May 11. This legislation will reauthorize the authority for the Food and Drug Administration (FDA) to accept user fees - paid by manufacturers of drugs and medical devices - that account for $8 to $9 billion over 5 years and is over a quarter of all FDA funding. The reauthorizations are based on recommendations from industry and FDA after a public process.

Over the last two years, the HELP Committee led by Alexander and Murray has held 15 bipartisan briefings, including some with the House Energy and Commerce Committee, to hear from FDA and industry about the reauthorization. The HELP Committee held two bipartisan hearings, on March 21 and April 4, on the medical device and drug user fees. The committee held a markup on the bill on May 11, when two bipartisan amendments were adopted, and the committee overwhelmingly approved the bill -- voting 21 to 2.

 
Share:

Related Articles:


Recent Articles

Nashville's First Dedicated Clinic for Rape Exams Begins Taking Clients

Website includes interactive tool to help sexual assault victims determine if the SAFE Clinic is right for them

Read More

Practicing with Precision

Precision medicine holds great promise to tailor treatment in a manner that maximizes outcomes, yet a number of barriers exist that hinder the rapidly growing discipline's integration into daily practice.

Read More

Physician Spotlight: Brandon Downs, MD

Dr. Brandon Downs of Orthopaedic Specialists offers convenient, comprehensive services to patients who rely on his expertise in minimally invasive joint replacement and sports medicine.

Read More

Vanderbilt Bone & Joint Franklin Expands Staff, Adds Pediatric Services

Vanderbilt Bone & Joint Franklin greatly expands staff and adds pediatric services.

Read More

Regenerative Medicine in Orthopaedics

Regenerative medicine means less pain, more options for orthopaedic patients.

Read More

SJRI Opens Dickson Clinic

Southern Joint Replacement Institute opens Dickson clinic.

Read More

Health:Further Keynote Speakers Offer Energy And Insight

Although the annual Health:Further conference is best known for bringing innovative start-ups and investors together, the event also attracts healthcare and business organizations that have massive scale.

Read More

Industry Leaders Announce Innovative Orthopaedic Partnership

Saint Thomas Health, BlueCross BlueShield of Tennessee and Tennessee Orthopaedic Alliance recently announced a collaborative partnership for joint replacement.

Read More

Fighting the Good Fight

Franklin company mitigating cybersecurity risks for healthcare organizations nationwide.

Read More

Fighting the Good Fight

Franklin company mitigating cybersecurity risks for healthcare organizations nationwide.

Read More

Email Print
 
 

 

 


Tags:
FDA, Food & Drug Administration, HELP Committee, Lamar Alexander, Patty Murray, U.S. Senate
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: